Dimensional Fund Advisors
AGIO icon

Dimensional Fund Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Dimensional Fund Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.9M Buy
1,151,614
+147,273
+15% +$4.18M 0.01% 1637
2025
Q4 		$27.3M Sell
1,004,341
-16,860
-2% -$592K 0.01% 1824
2025
Q3 		$41M Sell
1,021,201
-84,892
-8% -$3.19M 0.01% 1628
2025
Q2 		$36.8M Sell
1,106,093
-155,980
-12% -$4.73M 0.01% 1664
2025
Q1 		$37M Sell
1,262,073
-66,992
-5% -$2.22M 0.01% 1626
2024
Q4 		$43.7M Sell
1,329,065
-233,118
-15% -$11M 0.01% 1587
2024
Q3 		$69.4M Sell
1,562,183
-633,902
-29% -$28.8M 0.02% 1292
2024
Q2 		$94.7M Sell
2,196,085
-382,473
-15% -$13.8M 0.02% 1002
2024
Q1 		$75.4M Sell
2,578,558
-18,206
-0.7% -$488K 0.02% 1175
2023
Q4 		$57.8M Buy
2,596,764
+137,873
+6% +$3.09M 0.02% 1335
2023
Q3 		$60.9M Buy
2,458,891
+195,073
+9% +$5.16M 0.02% 1213
2023
Q2 		$64.1M Buy
2,263,818
+172,467
+8% +$4.29M 0.02% 1182
2023
Q1 		$48M Buy
2,091,351
+438,272
+27% +$11.6M 0.02% 1354
2022
Q4 		$46.4K Buy
1,653,079
+174,690
+12% +$4.92M 0.01% 1355
2022
Q3 		$41.8M Buy
1,478,389
+135,232
+10% +$3.63M 0.02% 1371
2022
Q2 		$29.8M Buy
1,343,157
+332,541
+33% +$7.51M 0.01% 1642
2022
Q1 		$29.4M Buy
1,010,616
+285,215
+39% +$8.71M 0.01% 1760
2021
Q4 		$23.8M Buy
725,401
+184,903
+34% +$7.44M 0.01% 1892
2021
Q3 		$24.9M Buy
540,498
+256,725
+90% +$12.4M 0.01% 1893
2021
Q2 		$15.6M Sell
283,773
-6,433
-2% -$360K 0.01% 2163
2021
Q1 		$15M Sell
290,206
-555
-0.2% -$27.5K 0.01% 2148
2020
Q4 		$12.6M Sell
290,761
-34,845
-11% -$1.38M ﹤0.01% 2189
2020
Q3 		$11.4M Sell
325,606
-14,920
-4% -$654K ﹤0.01% 2128
2020
Q2 		$18.2M Sell
340,526
-44,620
-12% -$2.07M 0.01% 1923
2020
Q1 		$13.7M Buy
385,146
+49,471
+15% +$2.29M 0.01% 1959
2019
Q4 		$16M Buy
335,675
+78,655
+31% +$2.97M 0.01% 2154
2019
Q3 		$8.33M Buy
257,020
+82,860
+48% +$3.43M ﹤0.01% 2424
2019
Q2 		$8.69M Sell
174,160
-4,727
-3% -$253K ﹤0.01% 2443
2019
Q1 		$12.1M Sell
178,887
-3,263
-2% -$190K ﹤0.01% 2324
2018
Q4 		$8.4M Buy
182,150
+39,255
+27% +$2.42M ﹤0.01% 2419
2018
Q3 		$11M Buy
142,895
+42,200
+42% +$3.39M ﹤0.01% 2394
2018
Q2 		$8.48M Buy
100,695
+24,051
+31% +$2.1M ﹤0.01% 2496
2018
Q1 		$6.27M Buy
+76,644
New +$5.92M ﹤0.01% 2547
2015
Q4 		– Sell
-50,137
Closed -$3.54M – 3330
2015
Q3 		$3.54M Sell
50,137
-3,377
-6% -$330K ﹤0.01% 2646
2015
Q2 		$5.94M Buy
53,514
+7,185
+16% +$774K ﹤0.01% 2513
2015
Q1 		$4.37M Buy
46,329
+9,555
+26% +$1.07M ﹤0.01% 2604
2014
Q4 		$4.12M Buy
+36,774
New +$3.28M ﹤0.01% 2625

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Dimensional Fund Advisors's AGIO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Agios Pharmaceuticals (AGIO) stake by 15% in Q1 2026, buying an estimated $4.18M and bringing the position to 1,151,614 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1637.

Dimensional Fund Advisors first reported a position in AGIO in Q4 2014 and has held it in 37 quarters since. The position peaked at $94.7M in Q2 2024. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Dimensional Fund Advisors held 1,151,614 shares of Agios Pharmaceuticals worth $38.9M as of Q1 2026.
  • Dimensional Fund Advisors bought 147,273 Agios Pharmaceuticals shares in Q1 2026, an estimated $4.18M.
  • Agios Pharmaceuticals made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1637 holding.
  • Dimensional Fund Advisors first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 37 quarters since.
  • Dimensional Fund Advisors's Agios Pharmaceuticals position peaked at $94.7M in Q2 2024.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.